These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13106602)

  • 1. Hepatitis and cirrhosis of the liver.
    EISENMENGER WJ; KLATSKIN G; PATEK AJ; PAYNE MA
    Bull N Y Acad Med; 1954 Jan; 30(1):43-65. PubMed ID: 13106602
    [No Abstract]   [Full Text] [Related]  

  • 2. [The current status of treatment of chronic hepatitis, liver cirrhosis and of their complications].
    NEIGER A
    Ther Umsch; 1961 Jan; 18():4-11. PubMed ID: 13728202
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience in the treatment of acute and chronic hepatitis as well as of compensated and decompensated liver cirrhosis with the liver hydrolysate prohepar].
    RASBACH K
    Med Monatsschr; 1955 Apr; 9(4):232-6. PubMed ID: 14393497
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recent experiences in cortisone treatment of hepatitis and liver cirrhosis].
    MARKOFF N; MINDER E; CROLL H
    Dtsch Med Wochenschr; 1958 Dec; 83(49):2154-9. PubMed ID: 13609348
    [No Abstract]   [Full Text] [Related]  

  • 5. [The place of cortisone drugs in the treatment of chronic hepatitis and of liver cirrhosis].
    DIMITRIU CC; BULIGESCU L
    Med Interna (Bucur); 1961 May; 13():689-701. PubMed ID: 13722921
    [No Abstract]   [Full Text] [Related]  

  • 6. [The therapy of chronic hepatitis and liver cirrhoses with liver-mitochondrial suspensions].
    HOETZL HA
    Munch Med Wochenschr; 1960 Sep; 102():1670-4. PubMed ID: 13714958
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of health resort treatment of chronic hepatitis and liver cirrhosis with lipotropic factors as diet supplement].
    NOGALLER AM
    Sov Med; 1958 Oct; 22(10):65-74. PubMed ID: 13615523
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extents of daily activities allowed in chronic hepatitis and liver cirrhosis].
    Murai K; Tsuji H; Kawadoko T; Fujishima M
    Fukuoka Igaku Zasshi; 1989 Aug; 80(8):422-4. PubMed ID: 2583654
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glycosuria observed during delta-cortisone treatment of hepatitis and cirrhosis].
    DUPUY R; VALLIN J; DESSERTENNES F; GIRAUD P
    Arch Mal Appar Dig Mal Nutr; 1957 Mar; 46(3):192-5. PubMed ID: 13425762
    [No Abstract]   [Full Text] [Related]  

  • 10. Cortisone and ACTH in hepatitis and cirrhosis.
    SVARTZ N
    Acta Med Scand Suppl; 1953; 287():39. PubMed ID: 13137964
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hepatitis and cirrhosis].
    Demling L
    Munch Med Wochenschr; 1966 Nov; 108(44):2231-4. PubMed ID: 6015103
    [No Abstract]   [Full Text] [Related]  

  • 12. [ACTH and cortisone in therapy of hepatitis and cirrhosis].
    GELIN G
    Bull Mem Soc Med Hop Paris; 1954 May 14-21; 70(15-16):533-7. PubMed ID: 13190394
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of chronic liver diseases with liver hydrolysates].
    GORGES T; FRANZEN F
    Munch Med Wochenschr; 1954 May; 96(21):614-7. PubMed ID: 13176395
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous administration of liver extracts in hepatitis; preventive note.
    GIULINI R; PACE O
    Minerva Med; 1954 Sep; 45(77):733-7. PubMed ID: 13213762
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of liver parenchymal diseases with total liver extracts].
    LASCH F
    Gastroenterologia; 1954 Nov; 82(5):270-84. PubMed ID: 13232153
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evolutive liver disease and liver-protective drugs].
    Minerva Farm; 1958; 7(9-10):173-4. PubMed ID: 13600090
    [No Abstract]   [Full Text] [Related]  

  • 17. [Early treatment of degenerative diseases of the liver parenchyma].
    DONHARDT A
    Dtsch Z Verdau Stoffwechselkr; 1953; 9():256-60. PubMed ID: 13150962
    [No Abstract]   [Full Text] [Related]  

  • 18. [Triamcinolone in therapy of some liver diseases].
    GARAGNANI A; CAVASSINI GB
    Arch Ital Mal Appar Dig; 1959; 25(4):251-76. PubMed ID: 13618136
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical studies on the therapeutic effect of the liver hydrolysate prohepar in the therapy of liver diseases under control of functional disorders in protein and bile pigment metabolism].
    GOHR H; GORGES T
    Z Gesamte Inn Med; 1953 Dec; 8(23):1073-7. PubMed ID: 13170184
    [No Abstract]   [Full Text] [Related]  

  • 20. [Individual therapy of inflammatory liver diseases (conditions, difficulties, results)].
    Brühl W
    Z Allgemeinmed; 1969 Apr; 45(12):562-7. PubMed ID: 5785117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.